H.R.661 - Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025; MIRACLE Medical Technology Act of 2025 (119th Congress)
Summary
H.R. 661, also known as the MIRACLE Medical Technology Act of 2025, aims to enhance collaboration between the United States and Israel in the development and delivery of healthcare products and services. The bill directs the Secretary of Health and Human Services to establish a program that facilitates joint research, innovation, and regulatory harmonization. It also authorizes appropriations of $8 million per year from 2026 through 2030 to support these efforts.
Expected Effects
If enacted, this bill would likely lead to increased cooperation between US and Israeli entities in the healthcare sector. This could result in faster development of new medical technologies and improved healthcare delivery. The establishment of a joint United States-Israel Health Care Collaboration Center could serve as a hub for these activities.
Potential Benefits
- Accelerated development of medical technologies through joint research projects.
- Enhanced access to innovative healthcare solutions for both US and Israeli citizens.
- Increased opportunities for US companies in the Israeli market and vice versa.
- Improved healthcare systems management through the sharing of best practices.
- Strengthened international collaboration in combating diseases and developing vaccines.
Potential Disadvantages
- The bill relies on appropriations, which may not always be guaranteed.
- Potential for intellectual property disputes between collaborating entities.
- Risk of data privacy breaches if cybersecurity standards are not adequately addressed.
- The focus on collaboration with Israel may divert resources from other international partnerships.
- There is a risk that the program may not be effectively implemented, leading to limited impact.
Constitutional Alignment
The bill appears to align with the Constitution's broad goals of promoting the general welfare, as stated in the Preamble. Congress has the power to enact legislation related to healthcare and international cooperation under Article I, Section 8, which grants it the power to provide for the general welfare and regulate commerce with foreign nations. The specific allocation of funds would need to be consistent with the appropriations process outlined in the Constitution.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).